Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,858.00
Bid: 6,847.00
Ask: 6,850.00
Change: 1.00 (0.01%)
Spread: 3.00 (0.04%)
Open: 6,800.00
High: 6,921.00
Low: 6,779.00
Yest. Close: 6,857.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Silence Therapeutics Agrees Strategic Collaboration With AstraZeneca

Silence Therapeutics Agrees Strategic Collaboration With AstraZeneca

25 Mar 20 09:48

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

23 Mar 20 16:04

DIRECTOR DEALINGS SUMMARY: Plus500 Team Spend GBP14 Million On Shares

DIRECTOR DEALINGS SUMMARY: Plus500 Team Spend GBP14 Million On Shares

20 Mar 20 15:57

AstraZeneca's Lynparza gets new orphan designation in Japan

(Sharecast News) - AstraZeneca announced on Thursday that Lynparza, or 'olaparib', has been granted orphan drug designation in Japan for the maintenance treatment of germline BRCA-mutated (gBRCAm) curatively unresectable pancreatic cancer.

19 Mar 20 13:38

UPDATE 2-FTSE 100 rises after BoE's new rescue measures, midcaps stuck in the red

* FTSE bounces after BoE eases again* Recent sterling slide helps exporters, banks also gain* Joules, Playtech, Crest Nicholson scrap dividend* FTSE 100 up 1.4%, FTSE 250 down 1.4% (Updates with closing prices)By Sruthi ShankarMarch 19 (Reuters) - B...

19 Mar 20 10:48

Japan Gives AstraZeneca's Lynparza Orphan Status In Pancreatic Cancer

Japan Gives AstraZeneca's Lynparza Orphan Status In Pancreatic Cancer

19 Mar 20 09:02

Tuesday broker round-up

(Sharecast News) - Ti Fluid Systems: Citigroup downgrades to neutral with a target price of 140p.

17 Mar 20 13:00

UK BROKER RATINGS SUMMARY: Goldman Sachs Raises Pearson And Informa

UK BROKER RATINGS SUMMARY: Goldman Sachs Raises Pearson And Informa

17 Mar 20 09:23

AstraZeneca's Caspian Trial Confirms Survival Benefit Of Imfinzi

AstraZeneca's Caspian Trial Confirms Survival Benefit Of Imfinzi

17 Mar 20 09:14

AstraZeneca posts mixed update on lung cancer drug R&D

(Sharecast News) - Pharmaceuticals giant AstraZeneca issued a mixed update on recent research and development work on Tuesday.

17 Mar 20 09:02

Trump set to declare national emergency in US, freeing up funding

(Sharecast News) - The US is expected to declare a national emergency at the end of the week and call for a coordinated international response to contain the coronavirus and its economic fallout.

13 Mar 20 16:53

AstraZeneca's Lynparza, Cediranib Trial Fails To Meet Primary Endpoint

AstraZeneca's Lynparza, Cediranib Trial Fails To Meet Primary Endpoint

12 Mar 20 08:10

AstraZeneca reports disappointing results from latest 'Lynparza' trial

(Sharecast News) - AstraZeneca, alongside its partner MSD, announced high-level results from the phase 3 'GY004' trial on Thursday, which examined the efficacy and safety of the potential new medicine 'cediranib' added to 'Lynparza', or olaparib, when compared to platinum-based chemotherapy in patients with platinum-sensitive relapsed ovarian cancer.

12 Mar 20 07:32

LIVE MARKETS-Rising euro delivers double whammy for STOXXE

* Bourses fall in virus worries * Europe's bank at lowest since 2009 Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Thyagaraju Adinarayan...

6 Mar 20 16:29

LIVE MARKETS-Stock picking tips

* Bourses fall in virus worries * Europe's bank at lowest since 2009 Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Thyagaraju Adinarayan...

6 Mar 20 15:39

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.